Yulei Wang, PhD
Senior Fellow/Group Leader
Department of Translational Medicine/Oncology
Genentech
South San Francisco, CA
Seminar title: Hepatocellular Carcinoma: Biomarker Discovery, Disease Biology, and Clinical Translation
Yulei joined Genentech in 2011. Currently a Senior Fellow/Group Leader in the Department of Translational Medicine, Yulei has extensive experiences in leading biomarker subteams for supporting both early stage (i.e. ADC/TDC and the TGFb franchise) and late stage clinical programs (i.e. cancer immunotherapies in hepatobiliary cancers). She also leads a group of biomarker scientists and oversees translational/reverse translational activities in GI disease area and across Morpheus signal-seeking combination platform.
As a well-recognized innovative scientific leader with a passion for both patients and science, Yulei has been a champion in leading the translation and reverse translation studies in liver cancer and ovarian cancer disease areas as well as global combination immunotherapy development. By integrating cancer genomics, digital pathology, ctDNA and single cell multi-omics in clinical biomarker studies, her team has successfully linked biomarker discovery, disease biology and clinical translation to enable transformative drug development.
In addition to leading clinical biomarker studies, Yulei is an accomplished postdoc mentor and head of translation research laboratory. Her group focuses on understanding the heterogeneity of the disease biology, tumor immune microenvironment and stroma biology to guide the development of novel therapeutic and diagnostic strategies.
